News

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...
The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
The pharmaceutical firm Novo Nordisk is pursuing a multi-pronged strategy to regain market share that it has lost to Eli ...
CVS’s stock surges toward a one-year high after profit and revenue beat expectations, amid strength in the pharmacy business, ...
CVS Health said it will significantly expand access to the blockbuster weight loss drug Wegovy for patients covered by its ...
Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD.
Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic ...
Approximately 9,000 CVS locations will begin selling Wegovy for $499 per month to customers who pay cash out of pocket.